Click here for a live version of this chart.
The Biotech ETF has had a devil of a time getting above 92 this year. Right now it is trying again. The low volume numbers don't bode well but remember that ETF volume data can be tricky to interpret. A close above 92 would do wonders for this chart. Time will tell - as always.
Martin Pring analyzes the two areas that could see a significant upside move if a peace settlement in the conflict in Ukraine is reached.... READ MORE
David Keller explains how to spot when a stock transitions from distribution to accumulation, and how you can use scanning, alerts, and scheduled scans to find the next breakout.... READ MORE
Before We Dive In… John Murphy’s unofficial Law #11 (“Keep at it”) can easily be misread as a motivational statement or a clichéd “self-help” line. But if you read it closely, it may be the most technical law of them all. How so? It doesn’t explain a tool,... READ MORE
Weekly update on U.S. sector rotation using Relative Rotation Graphs.... READ MORE
Value stocks are showing signs of strength, but it will take strength from sectors such as Energy and Financials to push this asset group higher. Learn about which charts could provide clues on the value vs. growth trade. ... READ MORE
Since the April low, the S&P 500 has shifted from a strong uptrend into a clear consolidation. Dave Keller, CMT, introduces a “traffic light” charting technique to define key support and resistance levels—and spot when sideways markets finally break into accumulation or distribution.... READ MORE